Hay fever medications: which are permitted?

5 Jun 2019

In light of the recent rise in pollen levels, UK Anti-Doping (UKAD) has today published a useful guide on the anti-doping status of common hay fever medications.

Many over-the-counter products containing the ingredients listed below are permitted medications. However, several medical treatments for hay fever appear on the World Anti-Doping Agency (WADA) Prohibited List as being prohibited in-competition.

Therefore, UKAD reminds athletes to check the status of their medications using the Global Drug Reference Online (Global DRO) website.

Permitted hay fever medications:

  • Antihistamine tablets (acrivastine, cetirizine, fexofenadine, loratadine)
  • Eye drops (sodium cromoglicate)
  • Nasal sprays and drops
  • Glucocorticoid nasal sprays (beclometasone, betamethasone, budesonide, fluticasone)
  • Antihistamine nasal spray (azelastine)
  • Nasal drops (xylometazoline)

Hay fever medications prohibited in-competition:

  • Intramuscular triamcinolone injection – refer to the UKAD hay fever guidelines
  • Prednisolone tablets – requires a TUE, contact UKAD
  • Decongestant tablets containing pseudoephedrine (PSE) – refer to the Prohibited List Q&A section of the WADA website

If you can’t find what you are looking for on Global DRO, you can contact UKAD with your enquiry on substanceenquiry@ukad.org.uk.